Monday, November 23,  9:31 pm

Forward-looking intelligence allows you time to act. View this video on our restructuring content to see how you can benefit from our expertise.

Billionaire investor Carl Icahn has not given up on his quest for control of Biogen Idec Inc. and plans to nominate a new slate of board directors at the biotechnology company's next annual meeting.

Biogen received notice of Icahn's intent to nominate four directors and fix the size of the board at 13, the Cambridge, Mass., company said Friday in a statement. The company named the individuals as Alexander Denner, Richard Mulligan, Thomas Deuel and David Sidransky

This is a free preview of the content available in The Deal Pipeline. Subscribers enjoy access to the full story, as well as second-to-none research tools.

To request a demo, or, if you are an existing user to The Deal Pipeline, log in to your account, please scroll down and click the button.

Dig deeper, with Pipeline.

• 1597 in-depth records of M&A transactions in the healthcare sector
• 778 articles related to Carl Icahn
• 151 articles related to Biogen Idec
• 52 in-depth records of reorganization in the healthcare sector
• 10 years of news and analysis archives from the voice of The Deal Economy
  

Most searched keywords

• Deutsche Bank
• Skadden Arps
• Pinnacle Foods
• Concho Resources
• Agrium Inc.
• Birds Eye
• Cantor Fitzgerald
  
• Credit Suisse
• Windstream Corp.
  
• Goldman Sachs